| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |